Login / Signup

R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma.

Fengyi ZhaoYan QinJianliang YangPeng LiuXiaohui HeLiqiang ZhouShengyu ZhouLin GuiHaizeng ZhangXin WangShiyu JiangQiaofeng ZhongYu ZhouYuan-Kai Shi
Published in: Asia-Pacific journal of clinical oncology (2020)
R-CHOP immunochemotherapy plus surgery was associated with a superior prognosis compared with R-CHOP alone in Chinese PI-DLBCL population.
Keyphrases
  • diffuse large b cell lymphoma
  • minimally invasive
  • epstein barr virus
  • coronary artery bypass
  • surgical site infection
  • percutaneous coronary intervention
  • atrial fibrillation